Drawray
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 1
About Drawray
Drawray, founded in 2019, is dedicated to the field of in vitro diagnostics, focusing on innovative solutions for healthcare. The company operates out of Shenzhen, China. The founder's prior entrepreneurial experience is not documented., Ltd. specializes in developing, producing, and selling in vitro diagnostic (IVD) products primarily focused on point-of-care testing (POCT). The company offers a range of diagnostic solutions that include self-contained battery-operated devices, printers, and scanning heads, designed for use in emergency vehicles, clinical departments, and epidemic inspection stations. Notable features of their products include single-use reagent strips with an extended shelf life without the need to open the packaging, as well as advanced magnetic microparticle acridine chemiluminescence technology, which enables accurate and rapid testing. Their product line boasts a diverse array of testing capabilities, including patented assays for liver fibrosis, with results available in as little as 11 minutes., Ltd. operates through a business model that emphasizes direct sales and partnerships with healthcare providers. Revenue is generated primarily through the sale of its diagnostic devices and related reagents, with a structured pricing model that accommodates bulk purchases for larger institutions while also catering to smaller clinics. The company’s flagship products are designed for high throughput, with the capability to process up to 150 tests per hour, thus appealing to both direct consumers and business-to-business (B2B) clients. The transaction structures typically involve direct sales agreements, where healthcare providers place orders based on their testing needs, ensuring a steady stream of revenue aligned with the demand for diagnostic services. The company is working on launching new products aimed at expanding its range in the biopharmaceutical sector. Furthermore, Drawray is strategizing to penetrate new international markets, although specific regions have yet to be disclosed.
Who invested in Drawray
1 investor across 1 round
See all investors in Drawray
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 30, 2025
Amount
Undisclosed
Investors
Questions about Drawray
Who invested in Drawray?
Drawray has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Drawray raised?
Drawray has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Drawray last raise money?
Drawray's most recent round on record is a Series A, in Oct 2025.
What does Drawray do?
Drawray, founded in 2019, is dedicated to the field of in vitro diagnostics, focusing on innovative solutions for healthcare.
Where is Drawray headquartered?
Drawray is headquartered in Shenzhen, China.
Which VCs invest in companies like Drawray?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Drawray's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Drawray? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.